You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm's COVID-19 molecular offerings almost made up for the decline in routine testing resulting from the pandemic.
Roche, Shionogi, Janssen Pharmaceuticals, and Eisai will provide the charity with specimens from Alzheimer's disease patients who participated in clinical studies.
According to the registry's first dataset, more than 65 million tests have been manufactured and shipped across the US.
The researchers are developing an automated machine-learning approach to analyze the expression of protein markers associated with cervical cancer.
A comparison of four antibody tests available for coronavirus testing in the UK revealed that only the Siemens Healthineers assay met sensitivity requirements.
Sciex has discontinued the Topaz platform three years after its launch while Thermo Fisher aims to drive adoption of its Cascadion following a recent US launch.
Thermo Fisher has also applied to the Japanese Ministry of Health, Labor, and Welfare to expand the use of the Oncomine Dx Target test in Japan.
High-throughput sample prep is becoming critical to COVID-19 testing scale-up, but some labs are experiencing shortages at this stage in the testing workflow.
Lexent's technology integrates low-pass whole-genome sequencing, fragmentomics, and DNA methylation to detect early stage disease.
The algorithm provides automated assessments of objective and reproducible scanned slide images that can help with diagnosis and targeted treatment options.